课题基金 / 基金详情

Studies on genetic and microbiologicail quality of human tumor xenografts lines as a tool for animal experiments

Studies on genetic and microbiologicail quality of human tumor xenografts lines as a tool for animal experiments
作为动物实验工具的人类肿瘤异种移植物系的遗传和微生物质量研究
批准号:
05454690
负责人:
OHNISHI Yasuyuki
金额:
$3.52万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995

项目摘要

项目成果

OHNISHI Yasuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background : Human tumor xenografts (HTXs) are a useful tool for animal experiments especially for evaluation of new antitumor drugs. We have been establishing HTXs, and have developed tumor chemosensitivity panels for new drug evaluation using them.Purpose : With regard to quality control (problems in chanes into mouse type tumors and/or artificial cross-contamination among tumor lines), we studied genetic profiling, and effects of long-term passaging on tumor properties such as growth and chemosensitivities, and we discuss the use of cryopreservation stock of HTXs and periodic replacement in order to maintain reproducibility of the experimental results. Methods : We examined isozyme markers and DNA fingerprinting to identify species and individuality of the tumors, respectively. Growth curves and sensitivities to antitumor drugs were examined using HTXs with different passaging in nude mice. Results : Among the tumors we maintained, five human tumors were found to have changed to mouse origin from their isozyme markers and were excluded. We identified the individuality of tumors which we used for the chemosensitivity panels by DNA fingerprinting, and their properties were stable for long-term passaging in nude mice. However, growth speed and chemosensitivities to drugs were altered with long-term passaging, although DNA fingerprint analysis did not show any obvious changes with passaging. Conclusions : Genetic profiling, such as isozyme markers and DNA fingerprinting, is useful for identify individuality of experimental HTXs, and tumors should be renewed periodically even when there are no signs of artificial contamination when they are used in experiments which require continuous reproducibility of experimental results.
期刊论文(62)
专著(0)
科研奖励(0)
会议论文
Hiroshi Kijima: "Stability of ras oncogene mutation in the human tumor xenografts through serial passage." Anticancer Res.14. 2583-2588 (1994)
Hiroshi Kijima:“通过连续传代,人类肿瘤异种移植物中 ras 癌基因突变的稳定性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ohnishi, Y., Yoshimura, M.and Ueyama, Y.: "Lactic dehydrogenase virus (LDHV) contamination in human tumor xenografts and its elimination." J.Natl.Cancer Inst.87. 538-539 (1995)
Ohnishi, Y.、Yoshimura, M. 和 Ueyama, Y.:“人类肿瘤异种移植物中的乳酸脱氢酶病毒 (LDHV) 污染及其消除。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yasuyuki Ohnishi: "Practical role of genetic profiling and presevration stack of human tumor xenograft line as a tool in animal experiments for antitumordrug evaluation" Lab.Anim.sabmitted. (1996)
Yasuyuki Ohnishi:“人类肿瘤异种移植物系的基因分析和保存堆栈作为抗肿瘤药物评估动物实验工具的实际作用”Lab.Anim.sabished。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
30
    Establishment of human tumor xenotransplantation models as a pre-clinical assisting tool for translational research
    • 批准号:
      13480283
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.26万
    • 财政年份:
      2001
    • 负责人:
      OHNISHI Yasuyuki
    • 依托单位:
    Studies on in vivo evaluation system of treatment for cancer prevention and progression using cancer prone gene-engineered mice
    • 批准号:
      12558097
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      2000
    • 负责人:
      OHNISHI Yasuyuki
    • 依托单位:
    Knock-down mouse, a novel gene engineering mouse for use as a disease model
    • 批准号:
      11480251
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $9.41万
    • 财政年份:
      1999
    • 负责人:
      OHNISHI Yasuyuki
    • 依托单位:
    Improvement of human tumor xenograft-mouse model as a preclinical evaluation system of new drugs discovered and developed by the novel strategy against cancer
    • 批准号:
      08458278
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $1.73万
    • 财政年份:
      1996
    • 负责人:
      OHNISHI Yasuyuki
    • 依托单位:
    国内基金
    海外基金
    癌干细胞形成过程中microRNA的表达及其功能研究